This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07988/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07988/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB07988/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07988/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07988/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07988
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07988 n14:DB07988
dcterms:title
2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE
adms:identifier
n9:3571804 n10:DB07988 n11:99444459 n12:IN9 n13:4369080
n3:IUPAC-Name
n4:271B5313-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5319-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5318-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5315-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5316-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5317-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5311-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B530F-363D-11E5-9242-09173F13E4C5 n4:271B5312-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5310-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B531F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5320-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B531A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B531B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B531D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B531C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B531E-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5325-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5327-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5328-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5324-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5323-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5326-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5314-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5321-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5322-363D-11E5-9242-09173F13E4C5